Cite

HARVARD Citation

    Chow, W. et al. (2020). Results of a prospective phase 2 study of pazopanib in patients with surgically unresectable or metastatic chondrosarcoma. Cancer. 126 (1), pp. 105-111. [Online]. 
  
Back to record